Why Privia Health Group Inc’s (PRVA) Stock Is Down 4.50%

By Jenna Brashear
March 21, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Privia Health Group Inc before investing.

In this article, we go over a few key elements for understanding Privia Health Group Inc’s stock price such as:

  • Privia Health Group Inc’s current stock price and volume
  • Why Privia Health Group Inc’s stock price changed recently
  • Upgrades and downgrades for PRVA from analysts
  • PRVA’s stock price momentum as measured by its relative strength

About Privia Health Group Inc (PRVA)

Before we jump into Privia Health Group Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. It provides management services to each Medical Group though a local management services organization.

Want to learn more about Privia Health Group Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Privia Health Group Inc.

Learn More About A+ Investor

Privia Health Group Inc’s Stock Price as of Market Close

As of March 21, 2024, 4:00 PM, CST, Privia Health Group Inc’s stock price was $19.96.

Privia Health Group Inc is down 4.5% from its previous closing price of $20.90.

During the last market session, Privia Health Group Inc’s stock traded between $20.49 and $21.27. Currently, there are 118.12 million shares of Privia Health Group Inc stock available for purchase.

Privia Health Group Inc’s price-earnings (P/E) ratio is currently at 112.8, which is high compared to the Healthcare Facilities & Services industry median of 24.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Privia Health Group Inc Stock Price History

Privia Health Group Inc’s (PRVA) price is currently down 10.57% so far this month.

During the month of March, Privia Health Group Inc’s stock price has reached a high of $23.15 and a low of $19.76.

Over the last year, Privia Health Group Inc has hit prices as high as $30.15 and as low as $19.18. Year to date, Privia Health Group Inc’s stock is down 12.11%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Privia Health Group Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 20, 2024, there were 7 analysts who downgraded Privia Health Group Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Privia Health Group Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Privia Health Group Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Privia Health Group Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Privia Health Group Inc (PRVA) by visiting AAII Stock Evaluator.

Relative Price Strength of Privia Health Group Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 20, 2024, Privia Health Group Inc has a weighted four-quarter relative price strength of -13.48%, which translates to a Momentum Score of 26 and is considered to be Weak.

Want to learn more about how Privia Health Group Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Privia Health Group Inc Stock Price: Bottom Line

As of March 21, 2024, Privia Health Group Inc’s stock price is $19.96, which is down 4.5% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Privia Health Group Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Est Rev: Up 5% Screen: 21.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.